Rabin response to stock price drop..
This was posted by BIGSTEM from ICELL
Reply from Gary
I guess the 400 investors got his attention.
Gary's reply.
Bigstem,
I understand and share your frustration with the stock price. But you must know that we are extremely limited in what we can say about the status of the trials (for example, GERN’s trials began in October 2010 and they STILL don’t say anything). We are working on putting out information about the patients and the results, but we obviously just cannot publish a bunch of data; it has to be disseminated in a format that people can understand. We are working on this as quickly as we can. The stock, which has held in all year MUCH better than the other stem cell and small-cap biotech stocks is getting corrected. Am I frustrated about this? Absolutely. Is there anything I can do about it without violating terms of my trial agreements, patient confidentiality laws, FDA confidentiality requirements and top-tier medical industry reporting norms? No.
And the stock is not selling off because people on the message boards that you read are losing confidence in the company. Small cap and biotech investors have been obliterated this year, and this quarter in particular. Funds are blowing out of their holdings to show investors that they have no exposure to the sector at the end of the quarter.
Please feel free to follow up with additional questions.
Gary
AI
